GT

(endocrinology) Initialism of gain of thyroid.


BNP

brain natriuretic peptide
brain natriuretic peptide#English

(endocrinology) Initialism of brain natriuretic peptide.


andropause

From andro- + -pause, based on menopause.

(medicine, endocrinology) The male equivalent of the menopause in women; characterized by a decline in libido and overall energy.


ACTH

adrenocorticotropic hormone
adrenocorticotropic hormone#English

(endocrinology, biochemistry) Initialism of adrenocorticotropic hormone.


CNP

en-noun

CNP (countable and uncountable, plural CNPs)

C-type natriuretic peptide
w:C-type natriuretic peptide

(endocrinology) Initialism of C-type natriuretic peptide.


GD

(endocrinology) Initialism of gain of deiodinases: the sum activity of peripheral deiodinases.


statin

From the suffix -statin, from terms such as lovastatin and simvastatin.

(endocrinology) An inhibiting hormone; a hormone that is involved primarily in inhibiting the release of another hormone.


liberin

(endocrinology) A releasing hormone; a hormone that is involved primarily in stimulating the release of another hormone.


corticotropin

corticotropin (countable and uncountable, plural corticotropins)

(biochemistry, endocrinology) Synonym of adrenocorticotropic hormone


hypersecretion

hypersecretion (countable and uncountable, plural hypersecretions)


propylthiouracil

/ˌpɹəʊ.pʌɪl.θʌɪ.əʊˈjʊə.ɹə.sɪl/

/ˌpɹəʊ.pɪl.θʌɪ.əʊˈjʊə.ɹə.sɪl/

/ˌpɹoʊ.pəlˌθaɪ.oʊˈjʊɹ.əˌsɪl/

From propyl + -thiouracil (“uracil derivative”).

compound

(pharmacology, endocrinology) A thioamide drug, used to treat hyperthyroidism by decreasing the amount of thyroid hormone produced by the thyroid gland, which is associated with a risk of agranulocytosis.


melanocyte-stimulating hormone

en-noun

melanocyte-stimulating hormone (plural melanocyte-stimulating hormones)

(endocrinology, biochemistry) Any of a class of peptide hormones released by the pituitary gland that are involved in regulating the production of melanin.


atrial natriuretic peptide

atrial natriuretic peptide (plural atrial natriuretic peptides)

(biochemistry, endocrinology) A strong vasodilatory, peptide hormone, secreted by the cardiac muscle cells.


neuroendocrine signaling

(endocrinology) A type of cell signaling involving the release of a hormone from a nerve cell that has an effect on another cell.


releasing hormone

releasing hormone (plural releasing hormones)

(endocrinology) A hormone that is involved primarily in stimulating the release of another hormone.


endocrine disruptor

endocrine disruptor (plural endocrine disruptors)

These endocrine disruptors are everywhere: plastics, shampoos, cosmetics, cushions, pesticides, canned foods and A.T.M. receipts. They often aren’t on labels and can be difficult to avoid.

2021 February 20, Nicholas Kristof, “What Are Sperm Telling Us?”, in The New York Times, →ISSN:

(endocrinology) A chemical substance that hinders the normal functioning of the endocrine system in animals and human beings.


renin-angiotensin system

renin-angiotensin system (plural renin-angiotensin systems)

(endocrinology) A collection of hormones involved in the regulation of the body's blood pressure and water content.


melanotropin

melanocyte-stimulating hormone
melanocyte-stimulating hormone#English

(endocrinology, biochemistry) Synonym of melanocyte-stimulating hormone


Quigley scale

Proposed in 1995 by pediatric endocrinologist Charmian A. Quigley et al.

(endocrinology) A visual system for phenotypic grading of the genitalia, from "fully masculinized" to "fully feminized".


ECTS

(endocrinology) Initialism of European Calcified Tissue Society.


SPINA-GT

Abbreviation of structure parameter inference approach-gain of thyroid.

abbreviation of

(endocrinology) The secretory capacity of the thyroid (if calculated with the structure parameter inference approach).


SPINA-GD

Abbreviation of structure parameter inference approach-gain of deiodinases.

(endocrinology) The sum activity of peripheral deiodinases, if calculated with a structure parameter inference approach.


hypersecrete

en-verb

hypersecrete (third-person singular simple present hypersecretes, present participle hypersecreting, simple past and past participle hypersecreted)

hypersecretes (present singular third-person)
hypersecreting (participle present)
hypersecreted (participle past)
hypersecreted (past)

(transitive, intransitive, endocrinology) To secrete excessively.


APUD

Acronym of amine precursor uptake (and) decarboxylation.

acronym

More recently it has been proposed that the APUD cell types of the gastrointestinal and respiratory tracts originate from neuroendocrine-programmed ectoblast.

1981, F. T. Bosman, J. W. Louwerens, “APUD cells in teratomas.”, in The American journal of pathology, →PMID:

(usually attributive, endocrinology, of cells) That secrete low molecular weight polypeptide hormones, such as gastrin, secretin, cholecystokinin, and motilin.


Morquio syndrome

en-noun

Morquio syndrome (countable and uncountable, plural Morquio syndromes)

(medicine, endocrinology) A rare metabolic disorder in which the body cannot process certain types of sugar molecules known as glycosaminoglycans.


insulin resistance

(endocrinology) A pathological condition in which cells fail to respond normally to the hormone insulin.

inzulinrezisztencia

a pathological condition in which cells fail to respond normally to the hormone insulin


HAIR-AN syndrome

HAIR-AN syndrome (plural HAIR-AN syndromes)

polycystic ovary syndrome
polycystic ovary syndrome

(medicine, endocrinology) A rare disease in women which is a subset of polycystic ovary syndrome.


angiotensin (1-7)

renin-angiotensin system
renin-angiotensin system

cardiovascular system
cardiovascular system

(endocrinology) An active heptapeptide of the renin-angiotensin system (RAS) and a vasodilator agent that plays an important role in the cardiovascular system.


angiotensin converting enzyme 2

angiotensin converting enzyme 2 (uncountable)

(endocrinology) An enzyme attached to the membrane of cells in various organs and lowers blood pressure by catalyzing the hydrolysis of angiotensin II into angiotensin (1-7).


angiotensin converting enzyme 1

angiotensin converting enzyme 1 (uncountable)

(endocrinology) A central component of the renin-angiotensin system (RAS), which controls blood pressure by regulating the volume of fluids in the body.


comb test

In addition to the comb test, physiologists applied assays based on changes in fat deposits, body length and weight, and hair growth, in rats and guinea-pigs.

1994, Nelly Oudshoorn, Beyond the Natural Body: An Archeology of Sex Hormones, e-book edition, Routledge, published 2005, →ISBN, page 48:

(endocrinology) A test for whether a substance should be considered a male sex hormone.


Urbach-Wiethe disease

First officially reported in 1929 by Erich Urbach and Camillo Wiethe.

(pathology, endocrinology, medical genetics) A very rare recessive genetic disorder with varying symptoms that may include a hoarse voice, lesions and scarring on the skin, easily damaged skin with poor wound healing, dry, wrinkly skin, and beading of the papules around the eyelids.


preproorexin

(endocrinology, biochemistry) A precursor of orexin, selectively expressed in the lateral hypothalamic area.


guevedoce

From Spanish güevedoce, from Dominican Spanish güevos a los doce (“testicles at twelve”).

(medicine, endocrinology) In the Dominican Republic, a person born with male gonads, but who appears to have female external genitalia, as a result of a 5-alpha-reductase deficiency.


vasoactive intestinal peptide

vasoactive intestinal peptide (plural vasoactive intestinal peptides)

(medicine, endocrinology) A peptide hormone that is vasoactive in the intestine.


methylmalonic acidemia

(medical genetics, endocrinology) An autosomal recessive metabolic disorder that disrupts normal amino acid metabolism.


SPINA-GR

Abbreviation of structure parameter inference approach-gain of insulin receptor.

abbreviation of

(endocrinology) The insulin receptor gain, a calculated biomarker for insulin sensitivity (if calculated with the structure parameter inference approach).


SPINA-GBeta

Abbreviation of structure parameter inference approach-gain of beta cells.

(endocrinology) The maximum amount of insulin that beta cells can produce per time-unit, a calculated biomarker for pancreatic beta cell function (if calculated with the structure parameter inference approach).


LATS

lLong-acting thyroid stimulator
w:lLong-acting thyroid stimulator

(endocrinology) Initialism of lLong-acting thyroid stimulator.


MSH

(endocrinology, biochemistry) Initialism of melanocyte-stimulating hormone.


TBG

thyroxine-binding globulin
thyroxine-binding globulin#English

(endocrinology, biochemistry) Initialism of thyroxine-binding globulin.


SPINA-DI

Abbreviation of structure parameter inference approach-disposition index.

(endocrinology) The loop gain of insulin-glucose homeostasis, calculated from the product of secretory capacity of pancreatic beta cells (SPINA-GBeta) times insulin receptor gain (SPINA-GR).


Achilles tendon reflex time

en-noun

Achilles tendon reflex time (countable and uncountable, plural Achilles tendon reflex times)

First use appears c. 1934 in medical literature, although the exact date of its first use is uncertain.

half-relaxation time
half-relaxation time

(medicine, endocrinology) A measurement of the half-relaxation time of the Achilles tendon, used to diagnose disorders of the thyroid.


kwolu-aatmwol

From Simbari, literally, a female thing changing into a male thing.

Coordinate term: guevedoce

(medicine, endocrinology) In Papua New Guinea, a person born with male gonads, but who appears to have female external genitalia, as a result of a 5-alpha-reductase deficiency.